2023-2028 Global and Regional Point of Care Molecular Diagnostics Industry Status and Prospects Professional Market Research Report Standard Version

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Point of Care Molecular Diagnostics Market Size Analysis from 2023 to 2028
1.5.1 Global Point of Care Molecular Diagnostics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Point of Care Molecular Diagnostics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Point of Care Molecular Diagnostics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Point of Care Molecular Diagnostics Industry Impact
Chapter 2 Global Point of Care Molecular Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Point of Care Molecular Diagnostics (Volume and Value) by Type
2.1.1 Global Point of Care Molecular Diagnostics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Point of Care Molecular Diagnostics Revenue and Market Share by Type (2017-2022)
2.2 Global Point of Care Molecular Diagnostics (Volume and Value) by Application
2.2.1 Global Point of Care Molecular Diagnostics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Point of Care Molecular Diagnostics Revenue and Market Share by Application (2017-2022)
2.3 Global Point of Care Molecular Diagnostics (Volume and Value) by Regions
2.3.1 Global Point of Care Molecular Diagnostics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Point of Care Molecular Diagnostics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Point of Care Molecular Diagnostics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Point of Care Molecular Diagnostics Consumption by Regions (2017-2022)
4.2 North America Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Point of Care Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Point of Care Molecular Diagnostics Market Analysis
5.1 North America Point of Care Molecular Diagnostics Consumption and Value Analysis
5.1.1 North America Point of Care Molecular Diagnostics Market Under COVID-19
5.2 North America Point of Care Molecular Diagnostics Consumption Volume by Types
5.3 North America Point of Care Molecular Diagnostics Consumption Structure by Application
5.4 North America Point of Care Molecular Diagnostics Consumption by Top Countries
5.4.1 United States Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
5.4.2 Canada Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
5.4.3 Mexico Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Point of Care Molecular Diagnostics Market Analysis
6.1 East Asia Point of Care Molecular Diagnostics Consumption and Value Analysis
6.1.1 East Asia Point of Care Molecular Diagnostics Market Under COVID-19
6.2 East Asia Point of Care Molecular Diagnostics Consumption Volume by Types
6.3 East Asia Point of Care Molecular Diagnostics Consumption Structure by Application
6.4 East Asia Point of Care Molecular Diagnostics Consumption by Top Countries
6.4.1 China Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
6.4.2 Japan Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
6.4.3 South Korea Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 7 Europe Point of Care Molecular Diagnostics Market Analysis
7.1 Europe Point of Care Molecular Diagnostics Consumption and Value Analysis
7.1.1 Europe Point of Care Molecular Diagnostics Market Under COVID-19
7.2 Europe Point of Care Molecular Diagnostics Consumption Volume by Types
7.3 Europe Point of Care Molecular Diagnostics Consumption Structure by Application
7.4 Europe Point of Care Molecular Diagnostics Consumption by Top Countries
7.4.1 Germany Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.2 UK Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.3 France Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.4 Italy Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.5 Russia Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.6 Spain Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.9 Poland Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Point of Care Molecular Diagnostics Market Analysis
8.1 South Asia Point of Care Molecular Diagnostics Consumption and Value Analysis
8.1.1 South Asia Point of Care Molecular Diagnostics Market Under COVID-19
8.2 South Asia Point of Care Molecular Diagnostics Consumption Volume by Types
8.3 South Asia Point of Care Molecular Diagnostics Consumption Structure by Application
8.4 South Asia Point of Care Molecular Diagnostics Consumption by Top Countries
8.4.1 India Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Point of Care Molecular Diagnostics Market Analysis
9.1 Southeast Asia Point of Care Molecular Diagnostics Consumption and Value Analysis
9.1.1 Southeast Asia Point of Care Molecular Diagnostics Market Under COVID-19
9.2 Southeast Asia Point of Care Molecular Diagnostics Consumption Volume by Types
9.3 Southeast Asia Point of Care Molecular Diagnostics Consumption Structure by Application
9.4 Southeast Asia Point of Care Molecular Diagnostics Consumption by Top Countries
9.4.1 Indonesia Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.2 Thailand Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.3 Singapore Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.5 Philippines Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Point of Care Molecular Diagnostics Market Analysis
10.1 Middle East Point of Care Molecular Diagnostics Consumption and Value Analysis
10.1.1 Middle East Point of Care Molecular Diagnostics Market Under COVID-19
10.2 Middle East Point of Care Molecular Diagnostics Consumption Volume by Types
10.3 Middle East Point of Care Molecular Diagnostics Consumption Structure by Application
10.4 Middle East Point of Care Molecular Diagnostics Consumption by Top Countries
10.4.1 Turkey Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.3 Iran Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.5 Israel Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.6 Iraq Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.7 Qatar Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.9 Oman Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 11 Africa Point of Care Molecular Diagnostics Market Analysis
11.1 Africa Point of Care Molecular Diagnostics Consumption and Value Analysis
11.1.1 Africa Point of Care Molecular Diagnostics Market Under COVID-19
11.2 Africa Point of Care Molecular Diagnostics Consumption Volume by Types
11.3 Africa Point of Care Molecular Diagnostics Consumption Structure by Application
11.4 Africa Point of Care Molecular Diagnostics Consumption by Top Countries
11.4.1 Nigeria Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.2 South Africa Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.3 Egypt Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.4 Algeria Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.5 Morocco Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Point of Care Molecular Diagnostics Market Analysis
12.1 Oceania Point of Care Molecular Diagnostics Consumption and Value Analysis
12.2 Oceania Point of Care Molecular Diagnostics Consumption Volume by Types
12.3 Oceania Point of Care Molecular Diagnostics Consumption Structure by Application
12.4 Oceania Point of Care Molecular Diagnostics Consumption by Top Countries
12.4.1 Australia Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 13 South America Point of Care Molecular Diagnostics Market Analysis
13.1 South America Point of Care Molecular Diagnostics Consumption and Value Analysis
13.1.1 South America Point of Care Molecular Diagnostics Market Under COVID-19
13.2 South America Point of Care Molecular Diagnostics Consumption Volume by Types
13.3 South America Point of Care Molecular Diagnostics Consumption Structure by Application
13.4 South America Point of Care Molecular Diagnostics Consumption Volume by Major Countries
13.4.1 Brazil Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.2 Argentina Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.3 Columbia Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.4 Chile Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.6 Peru Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Point of Care Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Point of Care Molecular Diagnostics Business
14.1 Myriad Genetics
14.1.1 Myriad Genetics Company Profile
14.1.2 Myriad Genetics Point of Care Molecular Diagnostics Product Specification
14.1.3 Myriad Genetics Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Cepheid
14.2.1 Cepheid Company Profile
14.2.2 Cepheid Point of Care Molecular Diagnostics Product Specification
14.2.3 Cepheid Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Illumina Inc.
14.3.1 Illumina Inc. Company Profile
14.3.2 Illumina Inc. Point of Care Molecular Diagnostics Product Specification
14.3.3 Illumina Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Abbott
14.4.1 Abbott Company Profile
14.4.2 Abbott Point of Care Molecular Diagnostics Product Specification
14.4.3 Abbott Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Agilent Technologies Inc.
14.5.1 Agilent Technologies Inc. Company Profile
14.5.2 Agilent Technologies Inc. Point of Care Molecular Diagnostics Product Specification
14.5.3 Agilent Technologies Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Hoffmann-La Roche Ltd.
14.6.1 Hoffmann-La Roche Ltd. Company Profile
14.6.2 Hoffmann-La Roche Ltd. Point of Care Molecular Diagnostics Product Specification
14.6.3 Hoffmann-La Roche Ltd. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 GenePOC Inc.
14.7.1 GenePOC Inc. Company Profile
14.7.2 GenePOC Inc. Point of Care Molecular Diagnostics Product Specification
14.7.3 GenePOC Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 QIAGEN
14.8.1 QIAGEN Company Profile
14.8.2 QIAGEN Point of Care Molecular Diagnostics Product Specification
14.8.3 QIAGEN Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Hologic Inc.
14.9.1 Hologic Inc. Company Profile
14.9.2 Hologic Inc. Point of Care Molecular Diagnostics Product Specification
14.9.3 Hologic Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Genomic Health
14.10.1 Genomic Health Company Profile
14.10.2 Genomic Health Point of Care Molecular Diagnostics Product Specification
14.10.3 Genomic Health Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Beckman Coulter Inc
14.11.1 Beckman Coulter Inc Company Profile
14.11.2 Beckman Coulter Inc Point of Care Molecular Diagnostics Product Specification
14.11.3 Beckman Coulter Inc Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Siemens Healthcare GmbH
14.12.1 Siemens Healthcare GmbH Company Profile
14.12.2 Siemens Healthcare GmbH Point of Care Molecular Diagnostics Product Specification
14.12.3 Siemens Healthcare GmbH Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 DxNA LLC.
14.13.1 DxNA LLC. Company Profile
14.13.2 DxNA LLC. Point of Care Molecular Diagnostics Product Specification
14.13.3 DxNA LLC. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Abaxis, Bayer AG,
14.14.1 Abaxis, Bayer AG, Company Profile
14.14.2 Abaxis, Bayer AG, Point of Care Molecular Diagnostics Product Specification
14.14.3 Abaxis, Bayer AG, Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Johnson & Johnson Services Inc.
14.15.1 Johnson & Johnson Services Inc. Company Profile
14.15.2 Johnson & Johnson Services Inc. Point of Care Molecular Diagnostics Product Specification
14.15.3 Johnson & Johnson Services Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Biocartis
14.16.1 Biocartis Company Profile
14.16.2 Biocartis Point of Care Molecular Diagnostics Product Specification
14.16.3 Biocartis Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Binx Health Inc.
14.17.1 Binx Health Inc. Company Profile
14.17.2 Binx Health Inc. Point of Care Molecular Diagnostics Product Specification
14.17.3 Binx Health Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Grifols S.A.
14.18.1 Grifols S.A. Company Profile
14.18.2 Grifols S.A. Point of Care Molecular Diagnostics Product Specification
14.18.3 Grifols S.A. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Medtronic
14.19.1 Medtronic Company Profile
14.19.2 Medtronic Point of Care Molecular Diagnostics Product Specification
14.19.3 Medtronic Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Spartan Bioscience Inc.
14.20.1 Spartan Bioscience Inc. Company Profile
14.20.2 Spartan Bioscience Inc. Point of Care Molecular Diagnostics Product Specification
14.20.3 Spartan Bioscience Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Quidel Corporation
14.21.1 Quidel Corporation Company Profile
14.21.2 Quidel Corporation Point of Care Molecular Diagnostics Product Specification
14.21.3 Quidel Corporation Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.22 bioMérieux SA
14.22.1 bioMérieux SA Company Profile
14.22.2 bioMérieux SA Point of Care Molecular Diagnostics Product Specification
14.22.3 bioMérieux SA Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.23 Sysmex Corporation
14.23.1 Sysmex Corporation Company Profile
14.23.2 Sysmex Corporation Point of Care Molecular Diagnostics Product Specification
14.23.3 Sysmex Corporation Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.24 BD
14.24.1 BD Company Profile
14.24.2 BD Point of Care Molecular Diagnostics Product Specification
14.24.3 BD Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.25 OraSure Technologies Inc.
14.25.1 OraSure Technologies Inc. Company Profile
14.25.2 OraSure Technologies Inc. Point of Care Molecular Diagnostics Product Specification
14.25.3 OraSure Technologies Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.26 Bio-Rad Laboratories Inc.
14.26.1 Bio-Rad Laboratories Inc. Company Profile
14.26.2 Bio-Rad Laboratories Inc. Point of Care Molecular Diagnostics Product Specification
14.26.3 Bio-Rad Laboratories Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.27 Meridian Bioscience Inc.
14.27.1 Meridian Bioscience Inc. Company Profile
14.27.2 Meridian Bioscience Inc. Point of Care Molecular Diagnostics Product Specification
14.27.3 Meridian Bioscience Inc. Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.28 Danaher
14.28.1 Danaher Company Profile
14.28.2 Danaher Point of Care Molecular Diagnostics Product Specification
14.28.3 Danaher Point of Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Point of Care Molecular Diagnostics Market Forecast (2023-2028)
15.1 Global Point of Care Molecular Diagnostics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Point of Care Molecular Diagnostics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Point of Care Molecular Diagnostics Value and Growth Rate Forecast (2023-2028)
15.2 Global Point of Care Molecular Diagnostics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Point of Care Molecular Diagnostics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Point of Care Molecular Diagnostics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Point of Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Point of Care Molecular Diagnostics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Point of Care Molecular Diagnostics Consumption Forecast by Type (2023-2028)
15.3.2 Global Point of Care Molecular Diagnostics Revenue Forecast by Type (2023-2028)
15.3.3 Global Point of Care Molecular Diagnostics Price Forecast by Type (2023-2028)
15.4 Global Point of Care Molecular Diagnostics Consumption Volume Forecast by Application (2023-2028)
15.5 Point of Care Molecular Diagnostics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology